About Okihiro syndrome due to 20q13 microdeletion
Okihiro syndrome due to 20q13 microdeletion is a rare disease catalogued by Orphanet (ORPHA:261638). It is associated with the SALL4 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Okihiro syndrome due to 20q13 microdeletion trials.
Search ClinicalTrials.gov for "Okihiro syndrome due to 20q13 microdeletion" or filter by Orphanet code ORPHA:261638 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Okihiro syndrome due to 20q13 microdeletion trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Okihiro syndrome due to 20q13 microdeletion. Updated daily.